Archives
-
IWP-L6 as a Causal Wnt Signaling Probe
2026-08-24
IWP-L6 is a sub-nanomolar Porcupine inhibitor for dissecting how Wnt ligand processing controls developmental and metabolic phenotypes. This article presents an assay-first framework linking Porcn inhibition to Wnt-dependent O-GlcNAcylation, glycolysis, osteogenesis, and tissue morphogenesis.
-
How Dual-Action Inhibitors Rewire p38α Dephosphorylation
2026-08-23
The reference preprint shows that kinase inhibitors can do more than occupy the p38α active site: selected compounds also expose the activation-loop phosphothreonine to the WIP1 phosphatase. Structural and biochemical evidence supports a conformation-directed strategy that may improve control of kinase signaling, while also defining important limits for translating the findings into cytokine or disease models.
-
Anisomycin: Designing JNK Signaling Assays
2026-08-22
Anisomycin is a powerful JNK agonist for dissecting stress signaling, apoptosis, and pathway causality. This article connects its assay value to new findings on neuroligin 1 proteolysis and social memory maintenance while emphasizing experimental controls and interpretation.
-
ACE2, Mitochondrial Biogenesis, and Sepsis
2026-08-22
A February 2024 mouse study links ACE2 downregulation with sepsis-induced cardiomyopathy and identifies MasR-Sirt1-mediated mitochondrial biogenesis as a protective mechanism. By combining pharmacological ACE2 activation and inhibition with cardiac, inflammatory, oxidative, apoptotic, and mitochondrial readouts, the study provides a mechanistic framework for interpreting septic myocardial injury while highlighting the limits of probe-based evidence.
-
FH1 Small Molecule for Hepatocyte Maturation
2026-08-21
FH1 small molecule supports a practical route to more functional iPS-derived hepatocyte-like cells, with product information reporting higher albumin secretion, increased CYP3A4 levels, and reduced AFP. This guide translates those findings into a controlled culture workflow, assay strategy, and troubleshooting framework for liver research.
-
JHU-083: From Glutamate to Translational Redox Strategy
2026-08-20
JHU-083 offers a compartment-aware approach to glutaminase pathway research in experimental cerebral malaria and neurological disease models. By connecting glutamate biology with the paradoxical GSTA1–glutathione findings in hepatotoxicity, this article outlines a disciplined framework for mechanistic validation and translational study design.
-
ERCC1 Deficiency, p53, and Platinum Response in Lung Cancer
2026-08-20
Heyza and colleagues show that ERCC1 loss does not determine platinum sensitivity in isolation: retained wild-type p53 increases cisplatin hypersensitivity, whereas p53 disruption permits greater survival through altered interstrand-crosslink repair. The study supports joint evaluation of ERCC1, p53 status, apoptosis, and compensatory repair pathways when interpreting platinum responses.
-
Mitomycin C: DNA Damage Workflows for Cancer Research
2026-08-19
Mitomycin C enables controlled DNA crosslinking, replication-stress, and apoptosis experiments across lung, prostate, and colon cancer systems. This guide connects practical dosing and TRAIL-sensitization workflows with ERCC1–p53 biology to improve assay design, interpretation, and troubleshooting.
-
Nitrocefin: From Color Change to Inhibitor Discovery
2026-08-19
Nitrocefin is more than a rapid chromogenic cephalosporin substrate: it can serve as the experimental readout connecting β-lactamase biology with computational inhibitor discovery. This guide explains assay chemistry, workflow design, interpretation, and the practical implications of recent peptide-screening research.
-
1-Phenyl-2-Pentanol: Anti-Fibrotic Evidence
2026-08-18
A 2024 study identified 1-phenyl-2-pentanol from Moringa oleifera leaves and evaluated its ability to suppress TGF-β1-stimulated activation of human hepatic stellate cells. Combined marker analysis, proteomics, and molecular docking linked the compound’s anti-fibrotic effects to reduced extracellular-matrix signaling and modulation of the Wnt/β-catenin pathway.
-
Tetrazolium Red: From Viability Stain to Translation
2026-08-18
A translational perspective on Tetrazolium (chloride) as a mechanistically informed redox readout for mitochondrial activity, cell viability, and ischemic tissue injury.
-
ZIF8 Nanotheranostics for Ultrasound-Guided TNBC
2026-08-17
Li et al. developed FA-PEG@ZIF8@CIP, a folate-targeted, pH-responsive nanotheranostic platform that combines ultrasound imaging with Ciprofloxacin delivery for triple-negative breast cancer. The study links sonodynamic ROS production with chemotherapy and immunogenic cell death, providing a useful framework for evaluating multifunctional cancer nanomedicines.
-
LPS–TLR4–YAP1 Signaling in Hepatocyte Stemness
2026-08-17
Shao et al. identify portal-vein lipopolysaccharide as a niche-associated signal that maintains hepatocyte stemness through TLR4 and YAP1 activation. Their combination of in vivo depletion, receptor loss-of-function, hepatocyte culture, reprogramming, and portal-vein manipulation links a microbial product to hepatic progenitor-like behavior while also defining important limits for translation.
-
TDRD9 siRNA Nanoparticles in P. aeruginosa Lung Injury
2026-08-16
This study identifies TDRD9 as a regulator of neutrophil cuproptosis during Pseudomonas aeruginosa lung infection and develops hyaluronic acid-coated peptide nanoparticles for siRNA delivery. Silencing TDRD9 reduced neutrophil accumulation, lung injury, and inflammatory pathology in preclinical models, while human lung organoids provided additional translational support.
-
EZ Cap™ Cas9 mRNA (m1Ψ) Workflow Guide
2026-08-15
Build transient CRISPR-Cas9 experiments around Cap1-capped, m1Ψ-modified Cas9 mRNA for efficient genome editing in mammalian cells. This practical guide covers delivery design, assay controls, precision optimization, and troubleshooting beyond simply increasing the RNA dose.